Email Updates

You are here

Home

Testing and Linkage to Care for Injecting Drug Users in Kenya (TLCIDU Kenya)

Status
Completed
Phase
Open Label
Principal Investigator(s)
Ann Kurth & John Lizcano
Objective

This study will leverage a historic decision in Kenya to launch needle exchange programs and related services for the most-at-risk population. Investigators will seek out IDUs, deliver rapid HIV testing, point of care CD4 count and link to ART using peer case managers, and evaluate community viral load impact.

Prevention Option(s)
Treatment
Study Design
Controlled
Randomized
Open label
Arms and Assigned Interventions
Description
No Intervention: Control IDUs in the control arm will receive the behavioural survey, follow-up interviews, health education and training sessions on how to recruit peers, the rapid HIV test, and the point of care CD4 test but will not be assigned a peer case manager.
ARMs
Placebo Comparator
Description
Experimental: CD4 and Peer Case Management HIV-positives will receive prevention with positives (PwP) counselling and point of care CD4 counts. Those with CD4 <350/μL will be assigned a peer case manager to link the person to ART at study-participating HIV clinics, support ART and PwP adherence and care retention.
ARMs
Experimental
Official Code
NCT01557998
Trial Sponsors
New York University School of Medicine
March 2012
April 2015
Enrollment
4 500
18
Years
Population
Women
Men
Injecting drug users
HIV positive
Sites

National AIDS/STD Control Programme (NASCOP)

Nairobi
Kenya